NCT00053157 2022-10-05Sargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic AnemiaRoswell Park Cancer InstitutePhase NA Completed10 enrolled
NCT00003408 2013-03-26Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With CancerNational Cancer Institute (NCI)Phase 2 Completed40 enrolled